Gene Therapy in Retinitis Pigmentosa

Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Show Description +

Robert E. MacLaren, MB, ChB, DPHil, FRCOphth, FRCS, FACS, FMedSci, reviews the results of a study that evaluated gene therapy for x-linked retinitis pigmentosa, offering details on how early study results demonstrate functional improvement.

Posted: 9/22/2018

Keywords:

Euretina Vienna

•

Gene Therapy

•

Retinitis pigmentosa

Up Next

Can We Get Smaller Than 27-Gauge Instrumentation?

José García-Arumí, MD, PhD, Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Can Technology Lead to a Seamless Diagnosis?

William Tucker, MD

Management of RVO

Anat Loewenstein, MD

Trials on Steroids for Diabetic Eye Disease

Albert J. Augustin, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Understanding the ALTAIR Study

Masahito Ohji, MD

Three Exciting New Drugs

Pravin U. Dugel, MD

Value of Recent Surgical Innovations

José García-Arumí, MD, PhD

The One Thing Every Doctor Can Do to Improve Efficiency in the Office

Nadia K. Waheed, MD, MPH, Pravin U. Dugel, MD

Disrupted Imaging on OCTA

Nadia K. Waheed, MD, MPH

Micropulse Laser in BRVO

Matteo Forlini, MD

Back to All Videos

Gene Therapy in Retinitis Pigmentosa

Robert E. MacLaren, MB, ChB, DPhil, FRCOphth, FRCS, FACS, FMedSci

Posted: 9/22/2018

Keywords:

Euretina Vienna

•

Gene Therapy

•

Retinitis pigmentosa

Please log in to leave a comment.

Meeting Coverage:

EURETINA Congress

Gene Therapy in Retinitis Pigmentosa

Up Next

Gene Therapy in Retinitis Pigmentosa

More From EURETINA: 2018 Coverage